TITLE

ANGIOLOGIC MANIFESTATIONS OF CARDIOPULMONARY SCHISTOSOMIASIS "BILHARZIASIS"

AUTHOR(S)
Al-Naaman, Yousif D.; Shamma, Ahmed H.; Damluji, Salem F.; El-Sayed, Hamdy M.
PUB. DATE
January 1966
SOURCE
Angiology;Jan1966, Vol. 17 Issue 1, p40
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
1. A total of 104 pulmonary schistosomal cases have been studied (hematobium, 78 per cent; mansoni, 22 per cent). 2. Schistosomal lung lesions in the form of parenchymatous or vascular lesions occur in both types. 3. The parenchymatous lesion is a granulomatous reaction and is usually benign. It indicates a lesser degree of ova infestation and, apart from being mistaken for serious lung disease, is of no such clinical significance. 4. The vascular lung lesions are in the form of necrotising arteriolitis, endarteritis obliterans, and angiomatous malformation usually associated with pulmonary hypertension. The main clinical, phonocardiographic, radiographic, electrocardiographic and hemodynamic features are outlined. 5. There is an immunological, allergical, and/or autoimmune phenomenon operative in the production of bilharzial pulmonary fibrosis and corpulmonale.
ACCESSION #
16346955

 

Related Articles

  • Recent Understanding of Pulmonary Vascular Disease in COPD. Weissmann, Norbert // Current Medical Literature: Pulmonary Hypertension;2011 Supplement, p14 

    The article discusses the study concerning the pulmonary vascular disease in chronic obstructive pulmonary disease (COPD). According to the author, there is possibility that COPD is associated with pulmonary hypertension (PH). It also mentions the use of guinea pigs and transgenic mice as...

  • Functional Mechanism of Lung Mosaic CT Attenuation: Assessment with Deep-Inspiration Breath-Hold Perfusion SPECT-CT Fusion Imaging and Non-Breath-Hold Technegas SPECT. Suga, K.; Yasuhiko, K.; Iwanaga, H.; Tokuda, O.; Matsunaga, N. // Acta Radiologica;Feb2009, Vol. 50 Issue 1, p34 

    Background: The functional mechanism of lung mosaic computed tomography attenuation (MCA) in pulmonary vascular disease (PVD) and obstructive airway disease (OAD) has not yet been fully clarified. Purpose: To clarify the mechanism of MCA in these diseases by assessing the relationship between...

  • PVRI China Heart Congress 2012, August 10-11.  // PVRI Review;Jan-Dec2012, Vol. 4 Issue 1/2, p35 

    The article discusses a meeting on pulmonary vascular diseases sponsored by the Fuwai Hospital and the Pulmonary Vascular Research Institute (PVRI) that was held in China on August 10-11, 2012.

  • Pulmonary vascular disease: clinical.  // Thorax;Dec2005 Supplement 2, Vol. 60, pii87 

    The article presents abstracts on pulmonary vascular diseases. They include "Haemolytic Disorders Complicated by Pulmonary Hypertension," by C.A. Elliot, J. Wright, K. Ryan, M. Woodhead, I.J. Armstrong, T.S. Saba and D.G. Kiely, "Histology of Arteriolar Wall Remodelling in a Lung Volume...

  • MicroRNAs-control of essential genes: Implications for pulmonary vascular disease. Joshi, Sachindra R.; McLendon, Jared M.; Comer, Brian S.; Gerthoffer, William T. // Pulmonary Circulation;2011, Vol. 1 Issue 3, p357 

    During normal lung development and in lung diseases structural cells in the lungs adapt to permit changes in lung function. Fibroblasts, myofibroblasts, smooth muscle, epithelial cells, and various progenitor cells can all undergo phenotypic modulation. In the pulmonary vasculature occlusive...

  • PVRI Eastern Mediterranean Taskforce 2012.  // PVRI Review;Jan-Dec2012, Vol. 4 Issue 1/2, p36 

    The article presents a report of the Pulmonary Vascular Research Institute (PVRI) taskforce in the Eastern Mediterranean Region (EMR) for 2012. It highlights the 5th Annual Joint Pulmonary Hypertension Conference in Istanbul, Turkey and lists other important events in pulmonary hypertension...

  • Foreword.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 2, pIV 

    An introduction to the journal is presented in which the editor discusses the understanding, treatment, and management of pulmonary hypertension.

  • Primary Pulmonary Hypertension. Rich, Stuart; Dantzker, David R.; Ayres, Stephen M.; Bergofsky, Edward H.; Brundage, Bruce H.; Detre, Katherine M.; Fishman, Alfred P.; Goldring, Roberta M.; Groves, Bertron M.; Koerner, Spencer K.; Levy, Paul C.; Reid, Lynne M.; Vreim, Carol E.; Williams, George W. // Annals of Internal Medicine;Aug87, Vol. 107 Issue 2, p216 

    Examines baseline data from patients with primary pulmonary hypertension who have been entered in a national registry in the U.S. Recognition of pulmonary vascular disease as a primary cause of pulmonary hypertension; Demographic characteristics of the patients; Symptoms exhibited by the...

  • Portopulmpnary hypertension syndrome in schistosomiasis mansoni. Pereira Jr, G.A.; Bestetti, R.B.; Leite, M.P.B.; Santos, R.B.; Ramos, S.G.; Lucchesi, F.R.; Elias Jr, J. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jul2002, Vol. 96 Issue 4, p427 

    Portopulmonary hypertension syndrome (PPHS) is a complication of portal hypertension where the substrate is micro-vessel lesions which are indicative of plexogenic arteriopathy. PPHS has not been linked to pulmonary schistosomiasis. We report, to the best of our knowledge for the first time, a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics